Inborn errors of metabolism at the turn of the millennium

Croatian Medical Journal

Volumn 42, Issue 4, 2001, Pages 379-383

  Baric I ^a   Fumic K ^a   Hoffmann, G F ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Genetics,medical; Human genome project; Metabolism, inborn errors; Neonatal screening

Indexed keywords

ALPHA GLUCOSIDASE; ENZYME; RECOMBINANT DNA; VITAMIN;

DIAGNOSTIC PROCEDURE; DIET THERAPY; ENZYME REPLACEMENT; GENE THERAPY; HUMAN; INBORN ERROR OF METABOLISM; MEDICAL GENETICS; NEWBORN SCREENING; REVIEW; TECHNOLOGY; TRANSPLANTATION; VITAMIN SUPPLEMENTATION;

HUMAN GENOME PROJECT; HUMANS; INFANT, NEWBORN; MASS SCREENING; METABOLISM, INBORN ERRORS;

EID: 0034858608     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. The incidence of alkaptonuria. A study in chemical individuality
2. Occurrence of urinary acid mucopolysaccharides in the Hurler syndrome
3. Hurler and Hunter syndromes: Mutual correction of the defect in cultured fibroblasts
4. Inherited disorders of cholesterol biosynthesis
5. Carbohydrate-deficient glycoprotein syndrome: Beyond the screen
6. Defects in the synthesis of cysteinyl leukotrienes: A new group of inborn errors of metabolism
7. Creatine deficiency syndromes: A new perspective on metabolic disorders and diagnostic challenge
8. In vivo and in vitro NMR spectroscopy reveal a putative novel inborn error involving polyol metabolism
9. Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: A novel inborn error of branched-chain fatty acid and isoleucine metabolism
10. 2-methylbutyrylcoenzyme A dehydrogenase deficiency: A new inborn error of L-isoleucine metabolism
11. Alexander disease: New insights from genetics
12. Hemochromatosis in heterozygotes
13. The role of chaperone-assisted folding and quality control in inborn errors of metabolism: Protein folding disorders
14. Garrod's foresight; our hindsight
15. A candidate genetic risk factor for vascular disease: A common mutation in methylentetrahydrofolate reductase
16. Haplotype distribution and mutations at the PAH locus in Croatia
17. Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus, PAH, in a global representation of populations
18. The phenylalanine hydroxylase locus: A marker for the history of phenylketonuria and human genetic diversity
19. Prospective study of MS-MS newborn screening in Bavaria, Germany. Interim results
20. Molecular and functional characterisation of mild MCAD deficiency
21. Applications of mass spectrometry in the study of inborn errors of metabolism
22. Long-term prognosis in galactosaemia: Results of a survey of 350 cases
23. Enzyme therapy for Gaucher disease: The first 5 years
24. Gaucher's disease: A model for modern management of a genetic disease
25. Enzyme replacement and beyond
26. Enzyme replacement therapy in mucopolysaccharidosis I
27. Enzyme therapy for Pompe disease with recombinat human α-glucosidase from rabbit milk
28. In vitro inhibition and intracellular enhancement of lysosomal α-galactosidase A activity in Fabry lymphoblasts by I-deoxygalactonojirimycin and its derivatives
29. Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy
30. Liver repopulation for the treatment of metabolic diseases